The Ethics Committee on Assisted Reproductive Technology (ECART) considers, determines and monitors applications made by fertility clinics for certain assisted reproductive procedures and human reproductive research.
ECART can only consider applications for procedures that the Advisory Committee on Assisted Reproductive Technology (ACART) has issued guidelines and advice for. Established procedures do not need ethical approval from ECART.
|ECART review required||No ECART review required|
|Clinic-Assisted Surrogacy||Artificial Insemination|
|Donation of Eggs or Sperm between Certain Family members||Collection of Eggs or Sperm for the Purposes of Donation|
|Embryo Donation for Reproductive purposes||Egg and Embryo Cryopreservation|
|Creation and Use, for Reproductive Purposes, of an Embryo Created with Donated Eggs and Donated Sperm||In Vitro Fertilisation (IVF)|
|Preimplantation Genetic Diagnosis (PGD) with Human Leukocyte Antigen (HLA) Tissue Typing||Ovarian Tissue and Sperm Cryopreservation|
|Research on Gametes and Non-Viable Embryos||Intracytoplasmic Sperm Injection (ICSI)|
ECART’s work is guided by the HART Act principles–
- Importance of the health and well-being of children
- Promoting and preserving human health, safety and dignity of present and future generations
- Importance of informed consent
- Awareness of, and accessibility to, information about a child’s genetic origins
- Respect and consideration for Māori needs, values and beliefs
- Respect and consideration for different ethical, spiritual and cultural perspectives.